Cargando…
Advances in targeting the folate receptor in the treatment/imaging of cancers
The folate receptor (FR) is a recognised biomarker for tumour cells due to its overexpression on a large number of tumours. Consequently, the FR has been exploited by many diagnostic and therapeutic tools to allow targeted delivery to, and imaging of, cancer cells. Herein, we describe the many diffe...
Autores principales: | Fernández, Marcos, Javaid, Faiza, Chudasama, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890329/ https://www.ncbi.nlm.nih.gov/pubmed/29675145 http://dx.doi.org/10.1039/c7sc04004k |
Ejemplares similares
-
Correction: Use of pyridazinediones as extracellular cleavable linkers through reversible cysteine conjugation
por: Bahou, Calise, et al.
Publicado: (2022) -
Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target
por: Javaid, Faiza, et al.
Publicado: (2021) -
Targeting folate receptor alpha for cancer treatment
por: Cheung, Anthony, et al.
Publicado: (2016) -
Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere–cationic folate nanoconjugate
por: Elechalawar, Chandra Kumar, et al.
Publicado: (2019) -
Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones
por: Bahou, Calise, et al.
Publicado: (2018)